First of their kind, myrcene nanoparticles are central to a novel, time-released therapeutic for neuropathic pain LAS VEGAS, Nov. 20, 2018 /PRNewswire/ — GB Sciences, Inc. (OTCQB: GBLX) and the Universidad de Sevilla (USE) announce the filing of a provisional patent application on the…

View more at https://www.prnewswire.com:443/news-releases/gb-sciences-files-first-of-its-kind-provisional-patent-application-for-the-treatment-of-neuropathic-pain-using-time-released-myrcene-based-nanoparticles-300753453.html